PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Drynaria fortunei improved plasma lipid profiles in elderly female patients via regulation of Notch1-NLRP3 inflammasome-mediated inflammation [PMID:34907823]
Extracts and flavonoids significantly improved bone mineral density (BMD), trabecular microarchitecture, and biomechanical properties in ovariectomized rats and zebrafish larvae [PMID:41850642, PMID:35863613, PMID:32065504, PMID:25456426]
Total flavonoids of Drynaria fortunei alleviated joint inflammation by suppressing P. copri-mediated Th17 cell differentiation [PMID:41317812]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 15633809 (2004) — The effect of Gu-Sui-Bu (Drynaria fortunei) on bone cell activity. · The American journal of Chinese medicine
- 2.PMID: 12099280 (2002) — The effect of Gu-Sui-Bu (Drynaria fortunei J. Sm) on bone cell activities. · Biomaterials
- 3.PMID: 35863613 (2022) — Gu Sui Bu (Drynaria fortunei J. Sm.) antagonizes glucocorticoid-induced mineralization reduction in zebrafish larvae by modulating the activity of osteoblasts and osteoclasts. · Journal of ethnopharmacology
- 4.PMID: 34907823 (2022) — Drynaria fortunei improves lipid profiles of elderly patients with postmenopausal osteoporosis via regulation of Notch1-NLRP3 inflammasome-mediated inflammation. · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
- 5.PMID: 12485805